AC Immune (ACIU) Quick Ratio: History & Chart

AC Immune S.A.(ACIU)

Biotechnology · Lausanne, VD

$2.72+0.01 (+0.37%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About AC Immune S.A.

AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegenerative conditions rooted in protein misfolding, both preventatively and therapeutically. Leveraging its proprietary SupraAntigen and Morphomer platforms, the company engineers a range of vaccines, antibodies, and small molecules specifically designed to engage with aberrantly folded proteins implicated across various neurodegenerative disorders. Its pipeline features Crenezumab, a humanized, conformation-specific monoclonal antibody currently undergoing a Phase II clinical prevention trial for Alzheimer's disease (AD). Additionally, AC Immune is advancing ACI-24, an anti-Abeta vaccine candidate, which is in Phase II clinical evaluation for AD and has successfully completed a Phase Ib study for Down syndrome. Other key candidates include ACI-35, an anti-Tau vaccine candidate that has finished Phase Ib clinical assessment, and a Tau-positron emission tomography (PET) imaging tracer, also in Phase II development. Furthermore, the company is engaged in the research and development of small molecule inhibitors to prevent Tau aggregation, targeting AD and various NeuroOrphan indications. Early-stage efforts include discovery and preclinical programs for a spectrum of neurodegenerative diseases, encompassing diagnostic agents aimed at TDP-43, alpha-synuclein, and NLRP3. The company maintains strategic partnerships and licensing agreements with key industry players such as Genentech, Inc., Biogen International GmbH, Janssen Pharmaceuticals, Inc., Life Molecular Imaging SA, Eli Lilly and Company, and WuXi Biologics. Founded in 2003, AC Immune S.A. is headquartered in Lausanne, Switzerland.

Lausanne, VD

106 employees

www.acimmune.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martin Zügel

View full financials

ACIU Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

0.93

QUICK RATIO (ACID-TEST) AVG TTM

1.06

QUICK RATIO (ACID-TEST) AVG 3Y

3.50

QUICK RATIO (ACID-TEST) AVG 5Y

7.00

QUICK RATIO (ACID-TEST) AVG 10Y

11.67

QUICK RATIO (ACID-TEST) AVG 15Y

N/A

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

-12.26%

CURRENT VS 3Y AVG

-73.35%

CURRENT VS 5Y AVG

-86.69%

CURRENT VS 10Y AVG

-92.02%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

2.99

median of 511 covered companies

CURRENT VS SECTOR MEDIAN

-68.84%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
AC Immune S.A. (ACIU)	$276.82M	0.93	1.06	3.50	7.00
Aurora Cannabis Inc. (ACB)vs ›	$283.69M	2.80	2.74	2.22	2.48
Fulcrum Therapeutics, Inc. (FULC)vs ›	$283.83M	31.35	25.02	20.04	16.05
Century Therapeutics, Inc. (IPSC)vs ›	$269.80M	8.28	3.73	7.03	8.20
Indaptus Therapeutics, Inc. (INDP)vs ›	$284.24M	19.48	1.73	4.11	4.35
Fate Therapeutics, Inc. (FATE)vs ›	$285.57M	4.85	6.69	6.56	6.64
EyePoint Pharmaceuticals, Inc. (EYPT)vs ›	$266.62M	4.46	8.30	6.73	6.78
BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›	$288.39M	4.69	11.27	11.27	11.27
Anika Therapeutics, Inc. (ANIK)vs ›	$264.05M	3.19	3.85	4.21	4.14
Eupraxia Pharmaceuticals Inc. (EPRX)vs ›	$261.48M	16.00	13.11	8.33	7.81

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

AC Immune S.A. (ACIU)

$276.82M

0.93

1.06

3.50

7.00

Aurora Cannabis Inc. (ACB)vs ›

$283.69M

2.80

2.74

2.22

2.48

Fulcrum Therapeutics, Inc. (FULC)vs ›

$283.83M

31.35

25.02

20.04

16.05

Century Therapeutics, Inc. (IPSC)vs ›

$269.80M

8.28

3.73

7.03

8.20

Indaptus Therapeutics, Inc. (INDP)vs ›

$284.24M

19.48

1.73

4.11

4.35

Fate Therapeutics, Inc. (FATE)vs ›

$285.57M

4.85

6.69

6.56

6.64

EyePoint Pharmaceuticals, Inc. (EYPT)vs ›

$266.62M

4.46

8.30

6.73

6.78

BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›

$288.39M

4.69

11.27

Anika Therapeutics, Inc. (ANIK)vs ›

$264.05M

3.19

3.85

4.21

4.14

Eupraxia Pharmaceuticals Inc. (EPRX)vs ›

$261.48M

16.00

13.11

8.33

7.81

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for AC Immune S.A. (ACIU)?

The quick ratio (acid-test) for ACIU stock is 0.93.

Is AC Immune S.A.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 0.93 is 87% below its 5-year average of 7.00, near the low end of its 5-year range (0.87–17.12).

What is the TTM average quick ratio (acid-test) for AC Immune S.A. (ACIU)?

The TTM average quick ratio (acid-test) for ACIU stock is 1.06.

What is the 3Y average quick ratio (acid-test) for AC Immune S.A. (ACIU)?

The 3Y average quick ratio (acid-test) for ACIU stock is 3.50.

What is the 5Y average quick ratio (acid-test) for AC Immune S.A. (ACIU)?

The 5Y average quick ratio (acid-test) for ACIU stock is 7.00.

What is the 10Y average quick ratio (acid-test) for AC Immune S.A. (ACIU)?

The 10Y average quick ratio (acid-test) for ACIU stock is 11.67.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	0.93
2026-03-31	0.87
2025-12-31	1.02
2025-09-30	1.16
2025-06-30	1.33
2025-03-31	1.53
2024-12-31	1.71
2024-09-30	1.86
2024-06-30	1.80
2024-03-31	7.78
2023-12-31	9.22
2023-09-30	7.36
2023-06-30	8.89
2023-03-31	10.38
2022-12-31	11.16
2022-09-30	10.85
2022-06-30	13.28
2022-03-31	14.87
2021-12-31	10.12
2021-09-30	13.74
2021-06-30	17.12
2021-03-31	19.82
2020-12-31	16.53
2020-09-30	18.10
2020-06-30	20.63
2020-03-31	21.28
2019-12-31	16.72
2019-09-30	22.08
2019-06-30	21.90
2019-03-31	5.06
2018-12-31	14.78
2018-09-30	19.21
2018-06-30	9.65
2018-03-31	13.94
2017-12-31	13.37
2017-09-30	15.26
2017-06-30	21.85
2017-03-31	18.79
2016-12-31	15.61
2016-09-30	14.50
2016-06-30	12.39
2016-03-31	12.68
2015-12-31	13.01
2015-09-30	14.79
2015-06-30	11.54
2015-03-31	0.00
2014-12-31	6.71
2014-09-30	0.00
2014-06-30	0.00
2014-03-31	0.00

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

0.93

2026-03-31

0.87

2025-12-31

1.02

2025-09-30

1.16

2025-06-30

1.33

2025-03-31

1.53

2024-12-31

1.71

2024-09-30

1.86

2024-06-30

1.80

2024-03-31

7.78

2023-12-31

9.22

2023-09-30

7.36

2023-06-30

8.89

2023-03-31

10.38

2022-12-31

11.16

2022-09-30

10.85

2022-06-30

13.28

2022-03-31

14.87

2021-12-31

10.12

2021-09-30

13.74

2021-06-30

17.12

2021-03-31

19.82

2020-12-31

16.53

2020-09-30

18.10

2020-06-30

20.63

2020-03-31

21.28

2019-12-31

16.72

2019-09-30

22.08

2019-06-30

21.90

2019-03-31

5.06

2018-12-31

14.78

2018-09-30

19.21

2018-06-30

9.65

2018-03-31

13.94

2017-12-31

13.37

2017-09-30

15.26

2017-06-30

21.85

2017-03-31

18.79

2016-12-31

15.61

2016-09-30

14.50

2016-06-30

12.39

2016-03-31

12.68

2015-12-31

13.01

2015-09-30

14.79

2015-06-30

11.54

2015-03-31

0.00

2014-12-31

6.71

2014-09-30

0.00

2014-06-30

0.00

2014-03-31

0.00

Quick Ratio (Acid-Test): 0.93

ACIU Quick Ratio

ACIU Average Quick Ratio (Acid-Test) Chart

ACIU Current vs Average Quick Ratio (Acid-Test) Chart

ACIU Quick Ratio (Acid-Test) Metrics

ACIU Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

ACIU Quick Ratio (Acid-Test) History

Related Metrics